MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Environment


GE Global Research Center

The GE Global Research Center is located on a 600-acre site in Niskayuna, New York. The various R&D buildings provide 1.25 million square feet of laboratory, library and office space. The center is equipped with a breadth and scope of equipment that is rarely found anywhere in the world (see also A.8.5.).

Of approximately 1700 employees at the Niskayuna site, about 1100 are staff scientists, engineers, and technicians, representing all of the major scientific disciplines. One of the key strengths of the technical team is that personnel assigned to the proposed project have access to the technical diverse members of the GE Research Staff, providing quick solutions to unforeseen problems.

In addition, GE is recognized as a world leader in medical equipment development and manufacturing as well as advanced semiconductor packaging and integration, critical technologies upon which the proposed program will draw. The CCNE-TR will significantly leverage these resources for both our nanotechnology and molecular imaging effort with direct involvement of GE Scientists (e.g., Dr. Filkins, S. Lomnes, D. Stutz). It is also highly likely that as our efforts reach commercialization stages that GE will be a key asset to this CCNE-TR.

[ Back ]
crumpnews events